Company / Return on Equity (ROE)
Teladoc Health, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-14.5%
FY2025
5-year range
-591.9% / -2.7%
FY2021-FY2025
Trend
+78.5%
vs FY2024
Sector context
#113 of 147
Health Care
What the data says
Teladoc Health, Inc. reports negative total equity of -14.5% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-14.5% in FY2025 with a 5-year CAGR of -11.4%.
Declined from -9.5% to -14.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +577.4pp
- 5-Year Change
- -11.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 147This company -14.5% Sector average -3.1%
▼
-363.4% below sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 78.5% year-over-year.
- Currently 11.3pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.5% | +78.5% |
| FY2024 | -67.2% | -609.1% |
| FY2023 | -9.5% | +98.4% |
| FY2022 | -591.9% | -22068.5% |
| FY2021 | -2.7% | +12.5% |
| FY2020 | -3.0% | +68.7% |
| FY2019 | -9.8% | -1.8% |
| FY2018 | -9.6% | +49.9% |
| FY2017 | -19.1% | +40.6% |
| FY2016 | -32.1% | +1.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026